{
    "ticker": "ANIX",
    "name": "Anixa Biosciences, Inc.",
    "description": "Anixa Biosciences, Inc. is a biotechnology company focused on developing innovative therapeutic and diagnostic solutions to address unmet medical needs. Founded in 2017 and headquartered in San Jose, California, Anixa aims to revolutionize cancer treatment and prevention through its proprietary technologies. The company is particularly recognized for its work in immuno-oncology, developing a novel therapeutic approach that harnesses the power of the immune system to fight cancer. Anixa's lead product candidate, a vaccine for ovarian cancer, is currently in clinical trials, with the potential to provide a much-needed preventative option for women at high risk. In addition to its cancer vaccine, Anixa is also engaged in developing a unique diagnostic platform designed to detect various cancers early, enhancing treatment outcomes. The company collaborates with leading research institutions to advance its scientific discoveries and has a strong commitment to bringing innovative medical solutions to market. Anixa's vision is to utilize cutting-edge science to improve patient outcomes and ultimately contribute to the fight against cancer.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Jose, California, USA",
    "founded": "2017",
    "website": "https://www.anixabio.com",
    "ceo": "Dr. Amit Kumar",
    "social_media": {
        "twitter": "https://twitter.com/AnixaBiosci",
        "linkedin": "https://www.linkedin.com/company/anixa-biosciences/"
    },
    "investor_relations": "https://www.anixabio.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. Amit Kumar",
            "position": "CEO"
        },
        {
            "name": "Dr. Manish Singh",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "Ovarian Cancer Vaccine"
            ]
        },
        {
            "category": "Diagnostics",
            "products": [
                "Cancer Detection Platform"
            ]
        }
    ],
    "seo": {
        "meta_title": "Anixa Biosciences, Inc. | Innovative Cancer Therapeutics and Diagnostics",
        "meta_description": "Learn about Anixa Biosciences, Inc., a biotechnology company focused on developing groundbreaking cancer therapies and diagnostics. Explore Anixa's innovative solutions and contributions to oncology.",
        "keywords": [
            "Anixa",
            "Biotechnology",
            "Cancer Treatment",
            "Ovarian Cancer Vaccine",
            "Immuno-oncology",
            "Cancer Diagnostics"
        ]
    },
    "faq": [
        {
            "question": "What is Anixa Biosciences known for?",
            "answer": "Anixa Biosciences is known for developing innovative cancer therapeutics and diagnostics, particularly in immuno-oncology."
        },
        {
            "question": "Who is the CEO of Anixa Biosciences?",
            "answer": "Dr. Amit Kumar is the CEO of Anixa Biosciences, Inc."
        },
        {
            "question": "Where is Anixa Biosciences headquartered?",
            "answer": "Anixa Biosciences is headquartered in San Jose, California, USA."
        },
        {
            "question": "What are Anixa's main products?",
            "answer": "Anixa's main products include an ovarian cancer vaccine and a cancer detection platform."
        },
        {
            "question": "When was Anixa Biosciences founded?",
            "answer": "Anixa Biosciences was founded in 2017."
        }
    ],
    "competitors": [
        "CRMD",
        "CLVS",
        "EDIT",
        "BCRX"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "MRNA",
        "BMY"
    ]
}